Ignite Creation Date:
2025-12-24 @ 4:51 PM
Ignite Modification Date:
2025-12-27 @ 4:40 AM
Study NCT ID:
NCT04044950
Status:
WITHDRAWN
Last Update Posted:
2020-09-22
First Post:
2019-08-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal Cancer
Sponsor:
National Cancer Institute (NCI)
Organization: